Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 中国铁路通信信号股份有限公司(简称:中国通号,股票代码:688009.SH,03969.HK)是国务院国资委直接监管的大型中央企业,是以轨道交通控制技术为特色的高科技产业集团,全球领先的轨道交通控制系统提供商。中国通号拥有投融资、设计研发、系统集成、装备制造、工程服务、运营维护完整产业链,是中国轨道交通控制系统设备制式、技术标准及产品标准的归口单位。近年来,中国通号连续四年获得中央企业经营业绩考核A级,2015年成功登陆香港联合交易所,2019年作为首个中央企业和首个A+H股公司首批登陆上交所科创板,现有14家重要二级企业,员工总数2万余人。 中国通号是保障国家轨道交通安全运营的核心企业,是我国高铁列控系统技术民族产业的代表者,是我国高铁最核心技术引领全球铁路行业进步的佼佼者。中国通号世界领先的列控技术为我国15万公里铁路、超4万公里高铁提供安全保障,建立完善了6万多个高铁测试案例,超过国外跨国企业的总和,是我国高铁建设运营的突出优势和世界轨道交通行业的宝贵财富。近年来,中国通号成功研发时速200公里和350公里高铁自动驾驶技术,标志着我国高铁列车运行控制系统技术已经走在世界前列。 高铁列控系统是高铁的“大脑和中枢神经”,是中国高铁三大核心技术之一。中国通号坚持引进消化吸收再创新的技术路径,加快自主创新,实现了我国高铁、地铁全套列车控制系统技术的完全自主化和产品的100%国产化,完成了高铁列控系统(CTCS-3级)、高铁自动驾驶系统(CTCS-3+ATO )、地铁列控系统(CBTC)、城际铁路列控系统(CTCS-2+ATO)、中低速磁悬浮控制系统、货运编组站综合自动化系统、铁路综合智能运维系统、综合运输调度指挥系统等轨道交通核心自主技术的重大突破,将轨道交通核心技术牢牢掌握在自己手里,从根本上保障了国家铁路建设和运输安全,为落实“一带一路”倡议和高铁“走出去”提供核心技术支撑。 作为中国高铁建设的国家队和主力军,中国通号先后参与了我国京津城际、京沪高铁、武广高铁、哈大高铁、兰新高铁等国内全部重大高铁项目建设。为我国95%以上已开通运营高铁提供核心列控技术和装备;中国通号肩负自主创新使命,将成熟的高铁控制系统技术应用于城市轨道交通领域,先后参与北京、上海、广州、深圳、天津、南京、武汉等40多个城市的140余条地铁项目,市场占有率达到65%以上。作为中国高铁“走出去”联盟的重要一员,广泛参与印尼雅万高铁、匈塞铁路、中老铁路等10多个国家和地区的高铁项目并取得积极进展,向世界展示了“中国高铁”靓丽的国家名片。 中国通号始终牢记党中央赋予中央企业的使命,始终以发展民族产业和民族技术为己任,在保持轨道交通通信信号领域全球领先地位的同时,以“六核一体两翼”赋能轨道交通产业,辐射壮大新兴产业,构建“轨道交通+N”产业协同发展格局,加快向具有全球竞争力的世界一流企业迈进。 | ||||||||||||||||||||||||
Main Business | 轨道交通控制系统及其衍生业务,同时开展轨道交通配套工程施工业务、市政信息化及其配套工程总承包业务和海外轨道交通建设相关业务等 | ||||||||||||||||||||||||
Legal Representative | 楼齐良 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 李连清 | ||||||||||||||||||||||||
Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
Auditors | 致同会计师事务所(特殊普通合伙);安永华明会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 010-50809286 | ||||||||||||||||||||||||
Fax No | 010-50809075 | ||||||||||||||||||||||||
Website | www.crsc.cn | ||||||||||||||||||||||||
ir@crsc.cn | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 22/07/2019 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.320 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.170 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 4.156 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 58.278B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |